Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma - Deng, Tingting; Liu, Yang; Zhuang, Jialang; Tang, Yizhe; Huo, Qin (Frontiers in Oncology, 2022)